Bernd R. Seizinger's most recent trade in Aptose Biosciences Inc was a trade of 100,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aptose Biosciences Inc | Bernd R. Seizinger | FORMER DIRECTOR | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2026 | 100,000 | 0 | - | - | Stock Option (right to buy) | |
| Aptose Biosciences Inc | Bernd R. Seizinger | FORMER DIRECTOR | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2026 | 50,000 | 0 | - | - | Stock Option (right to buy) | |
| Aptose Biosciences Inc | Bernd R. Seizinger | FORMER DIRECTOR | Sale or transfer of securities back to the company at price $ 1.72 per share. | 30 Jun 2026 | 17,000 | 0 (0%) | 0% | 1.7 | 29,240 | Common Shares |
| Aptose Biosciences Inc | Bernd R. Seizinger | FORMER DIRECTOR | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2026 | 3,333 | 0 | - | - | Director Stock Option (Right to Buy) | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2026 | 12,555 | 12,555 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2026 | 3,135 | 48,910 (0%) | 0% | 0 | Common Stock | |
| Oncolytics Biotech Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2026 | 30,000 | 30,000 | - | - | Stock Option | |
| Oncolytics Biotech Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 16 Jan 2026 | 100,000 | 466,991 (2%) | 0% | 1.0 | 103,770 | Common Shares |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 4,185 | 4,185 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 1,045 | 45,775 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 2.68 per share. | 11 Oct 2024 | 10,000 | 44,730 (0%) | 0% | 2.7 | 26,800 | Common Stock |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,185 | 4,185 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 1,045 | 34,730 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 7.29 per share. | 13 Mar 2024 | 6,860 | 33,685 (0%) | 0% | 7.3 | 50,009 | Common Stock |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Mar 2024 | 3,430 | 3,430 | - | - | Tranche B Warrant | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Mar 2024 | 3,430 | 3,430 | - | - | Tranche A Warrant | |
| Aptose Biosciences Inc | Bernd Seizinger R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 3,333 | 3,333 | - | - | Director Stock Option (Right to Buy) | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 2,000 | 2,000 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 500 | 26,825 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 3.68 per share. | 06 Jun 2023 | 6,029 | 26,325 (0%) | 0% | 3.7 | 22,192 | Common Stock |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 3.63 per share. | 06 Jun 2023 | 4,068 | 20,296 (0%) | 0% | 3.6 | 14,764 | Common Stock |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 29,575 | 29,575 | - | - | Stock Option (right to Buy) | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 5,995 | 324,575 (1%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | Bernd R. Seizinger | Director | Purchase of securities on an exchange or from another person at price $ 0.71 per share. | 18 May 2022 | 50,000 | 318,580 (1%) | 0% | 0.7 | 35,500 | Common Stock |